Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

NCT00107718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: SB-485232

Sponsor

GlaxoSmithKline